<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Worldwide, platelet transfusions have increased substantially, especially in hematological patients </plain></SENT>
<SENT sid="1" pm="."><plain>The prophylactic and therapeutic indications for platelet substitution as well as the choice of platelet preparation are discussed for patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who need the highest platelet support </plain></SENT>
<SENT sid="2" pm="."><plain>Here we present our current strategy, i.e., prophylactic transfusions with random platelets in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and therapeutic transfusions with filtered random platelets in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients only </plain></SENT>
</text></document>